{"id":"https://openalex.org/W4299458342","doi":"https://doi.org/10.53986/ibjm.2022.0033","title":"Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study","display_name":"Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study","publication_year":2022,"publication_date":"2022-08-23","ids":{"openalex":"https://openalex.org/W4299458342","doi":"https://doi.org/10.53986/ibjm.2022.0033"},"language":"en","primary_location":{"id":"doi:10.53986/ibjm.2022.0033","doi":"https://doi.org/10.53986/ibjm.2022.0033","is_oa":true,"landing_page_url":"https://doi.org/10.53986/ibjm.2022.0033","pdf_url":"https://www.iberoamjmed.com/article/10.53986/ibjm.2022.0033/pdf/iberoamericanjm-4-4-191.pdf","source":{"id":"https://openalex.org/S4210216135","display_name":"Iberoamerican Journal of Medicine","issn_l":"2695-5075","issn":["2695-5075"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","fecyt-seal","latindex","scielo"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iberoamerican Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.iberoamjmed.com/article/10.53986/ibjm.2022.0033/pdf/iberoamericanjm-4-4-191.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080803322","display_name":"Eyy\u00fcp \u00c7avdar","orcid":"https://orcid.org/0000-0001-5885-3047","observed_orcids":["https://orcid.org/0000-0001-5885-3047"]},"institutions":[{"id":"https://openalex.org/I125454184","display_name":"Tekirda\u011f Nam\u0131k Kemal University","ror":"https://ror.org/01a0mk874","country_code":"TR","type":"education","lineage":["https://openalex.org/I125454184"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Eyyup Cavdar","raw_affiliation_strings":["Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey"],"raw_orcid":"https://orcid.org/0000-0001-5885-3047","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey","institution_ids":["https://openalex.org/I125454184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064417858","display_name":"Kubilay Karaboyun","orcid":"https://orcid.org/0000-0002-1783-8075","observed_orcids":["https://orcid.org/0000-0002-1783-8075"]},"institutions":[{"id":"https://openalex.org/I125454184","display_name":"Tekirda\u011f Nam\u0131k Kemal University","ror":"https://ror.org/01a0mk874","country_code":"TR","type":"education","lineage":["https://openalex.org/I125454184"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kubilay Karaboyun","raw_affiliation_strings":["Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey"],"raw_orcid":"https://orcid.org/0000-0002-1783-8075","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey","institution_ids":["https://openalex.org/I125454184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053054460","display_name":"Yakup \u0130ria\u011fa\u00e7","orcid":"https://orcid.org/0000-0001-7411-1705","observed_orcids":["https://orcid.org/0000-0001-7411-1705"]},"institutions":[{"id":"https://openalex.org/I125454184","display_name":"Tekirda\u011f Nam\u0131k Kemal University","ror":"https://ror.org/01a0mk874","country_code":"TR","type":"education","lineage":["https://openalex.org/I125454184"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Yakup Iriagac","raw_affiliation_strings":["Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey"],"raw_orcid":"https://orcid.org/0000-0001-7411-1705","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey","institution_ids":["https://openalex.org/I125454184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078547021","display_name":"Okan Avc\u0131","orcid":"https://orcid.org/0000-0003-3773-6620","observed_orcids":["https://orcid.org/0000-0003-3773-6620"]},"institutions":[{"id":"https://openalex.org/I125454184","display_name":"Tekirda\u011f Nam\u0131k Kemal University","ror":"https://ror.org/01a0mk874","country_code":"TR","type":"education","lineage":["https://openalex.org/I125454184"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Okan Avci","raw_affiliation_strings":["Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey"],"raw_orcid":"https://orcid.org/0000-0003-3773-6620","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey","institution_ids":["https://openalex.org/I125454184"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043498541","display_name":"S. Seber","orcid":"https://orcid.org/0000-0001-9081-2405","observed_orcids":["https://orcid.org/0000-0001-9081-2405"]},"institutions":[{"id":"https://openalex.org/I125454184","display_name":"Tekirda\u011f Nam\u0131k Kemal University","ror":"https://ror.org/01a0mk874","country_code":"TR","type":"education","lineage":["https://openalex.org/I125454184"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Erdo\u011fan Selcuk Seber","raw_affiliation_strings":["Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey"],"raw_orcid":"https://orcid.org/0000-0001-9081-2405","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tekirda\u011f Nam\u0131k Kemal University, Tekirda\u011f, Turkey","institution_ids":["https://openalex.org/I125454184"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080803322"],"corresponding_institution_ids":["https://openalex.org/I125454184"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.15982462,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"4","issue":"4","first_page":"191","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9679999947547913},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.972000002861023},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9760000109672546},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.996999979019165},{"id":"https://openalex.org/keywords/ca-15-3","display_name":"CA15-3","score":0.9829999804496765},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2778087150","wikidata":"https://www.wikidata.org/wiki/Q3997863","display_name":"Trastuzumab emtansine","level":5,"score":0.8268217444419861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8083841800689697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7515060901641846},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6883076429367065},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.6486806869506836},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.644713282585144},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6023330092430115},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5854745507240295},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5770054459571838},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5315271019935608},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.5010950565338135},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.47241535782814026},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4587850868701935},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4482453465461731},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.427834153175354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4218651056289673},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23793336749076843},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.06474199891090393}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.53986/ibjm.2022.0033","doi":"https://doi.org/10.53986/ibjm.2022.0033","is_oa":true,"landing_page_url":"https://doi.org/10.53986/ibjm.2022.0033","pdf_url":"https://www.iberoamjmed.com/article/10.53986/ibjm.2022.0033/pdf/iberoamericanjm-4-4-191.pdf","source":{"id":"https://openalex.org/S4210216135","display_name":"Iberoamerican Journal of Medicine","issn_l":"2695-5075","issn":["2695-5075"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","fecyt-seal","latindex","scielo"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iberoamerican Journal of Medicine","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:4db79f16413e4d81b97ea1819d6debea","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4db79f16413e4d81b97ea1819d6debea","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Iberoamerican Journal of Medicine, Vol 4, Iss 4, Pp 191-198 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.53986/ibjm.2022.0033","doi":"https://doi.org/10.53986/ibjm.2022.0033","is_oa":true,"landing_page_url":"https://doi.org/10.53986/ibjm.2022.0033","pdf_url":"https://www.iberoamjmed.com/article/10.53986/ibjm.2022.0033/pdf/iberoamericanjm-4-4-191.pdf","source":{"id":"https://openalex.org/S4210216135","display_name":"Iberoamerican Journal of Medicine","issn_l":"2695-5075","issn":["2695-5075"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","fecyt-seal","latindex","scielo"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iberoamerican Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4299458342.pdf","grobid_xml":"https://content.openalex.org/works/W4299458342.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1863700672","https://openalex.org/W1968590850","https://openalex.org/W1968813883","https://openalex.org/W1984007340","https://openalex.org/W1996755397","https://openalex.org/W2082818260","https://openalex.org/W2083442629","https://openalex.org/W2098460073","https://openalex.org/W2159967578","https://openalex.org/W2267844613","https://openalex.org/W2297381223","https://openalex.org/W2393325472","https://openalex.org/W2595081519","https://openalex.org/W2614773797","https://openalex.org/W2619710211","https://openalex.org/W2774481898","https://openalex.org/W2887448630","https://openalex.org/W2896524087","https://openalex.org/W2901397663","https://openalex.org/W2902218997","https://openalex.org/W2912923142","https://openalex.org/W2914242007","https://openalex.org/W3027348319","https://openalex.org/W3128646645","https://openalex.org/W3135149529","https://openalex.org/W3160931700","https://openalex.org/W3161506837","https://openalex.org/W4206299960","https://openalex.org/W4206548876","https://openalex.org/W4211123279","https://openalex.org/W4220930291","https://openalex.org/W4234081105"],"related_works":["https://openalex.org/W7119161205","https://openalex.org/W3160931700","https://openalex.org/W2292132270","https://openalex.org/W4367727991","https://openalex.org/W2137754029","https://openalex.org/W2765800970","https://openalex.org/W4403088816","https://openalex.org/W4241718091","https://openalex.org/W2297381223","https://openalex.org/W4414060151"],"abstract_inverted_index":{"Introduction:":[0],"Trastuzumab":[1],"emtansine":[2],"(T-DM1)":[3],"is":[4,249],"one":[5],"of":[6,32,41,64,225],"the":[7,30,61,100,108,141,150,197,202,226],"effective":[8],"treatment":[9,85,89],"options":[10],"in":[11,60,68,99,196,222,232],"human":[12],"epidermal":[13],"growth":[14],"factor":[15],"receptor":[16],"2":[17,93],"(HER2)":[18],"positive":[19],"breast":[20,74],"cancer":[21,75],"patients.":[22,235],"In":[23,149,201],"this":[24],"study,":[25],"we":[26],"aimed":[27],"to":[28,81,107,168,216],"find":[29],"effect":[31],"T-DM1":[33,42,88,136,248],"on":[34],"survival,":[35],"its":[36],"tolerability":[37],"and":[38,45,83,86,119,140,161,183,245,252,263],"prognostic":[39,271],"factors":[40,170,272],"treatment.":[43],"Material":[44],"methods:":[46],"The":[47,130,236],"study":[48,55],"was":[49,137,146,214],"designed":[50],"as":[51],"a":[52,65,78,250],"single-center,":[53],"retrospective":[54],"that":[56,255],"included":[57,98],"patients":[58,71,274],"treated":[59],"oncology":[62],"department":[63],"university":[66],"hospital":[67],"Turkey.":[69],"HER2-positive":[70],"with":[72,172],"metastatic":[73],"who":[76],"had":[77],"progression":[79],"response":[80],"trastuzumab":[82],"taxane":[84],"received":[87],"for":[90,112,126,135,194,205,273],"at":[91],"least":[92],"months":[94,139],"between":[95],"2016-2022":[96],"were":[97,104,124,166,241],"study.":[101],"Adverse":[102,113],"events":[103],"defined":[105],"according":[106],"Common":[109],"Terminology":[110],"Criteria":[111],"Events":[114],"v5.0":[115],"(CTCAE).":[116],"Kaplan-Meier":[117],"methodology":[118],"Cox":[120],"proportional":[121],"hazard":[122],"modelling":[123],"used":[125],"survival":[127,133,144],"analyses.":[128],"Results:":[129],"median":[131,142],"progression-free":[132],"(mPFS)":[134],"10.4":[138],"overall":[143],"(mOS)":[145],"22":[147],"months.":[148],"created":[151],"univariate":[152],"cox":[153],"regression":[154,203],"model,":[155],"liver":[156],"metastasis,":[157,259],"ECOG":[158,178,208,260],"performance":[159,179,209,261],"status,":[160,262],"pre-treatment":[162,264],"serum":[163,184,265],"CA":[164,185,266],"15-3":[165,186,267],"found":[167,215],"be":[169,217],"associated":[171],"PFS.":[173],"Liver":[174,258],"metastasis":[175],"(HR=2.54,":[176],"p=0.019),":[177],"status":[180,210],"(HR=4.66,":[181],"p=0.002),":[182],"(HR=":[187,211],"2.55,":[188],"p=0.041)":[189],"maintained":[190],"their":[191],"statistical":[192],"significance":[193],"PFS":[195],"established":[198],"multivariate":[199],"analysis.":[200],"analysis":[204],"OS,":[206],"only":[207],"2.61,":[212],"p=0.023)":[213],"prognostic.":[218],"While":[219],"toxicity":[220,230],"occurred":[221],"46":[223],"(82.1%)":[224],"patients,":[227],"grade":[228],"3-4":[229],"developed":[231],"10":[233],"(17.9%)":[234],"most":[237],"common":[238],"side":[239],"effects":[240],"anemia,":[242],"thrombocytopenia,":[243],"fatigue":[244],"nausea.":[246],"Conclusions:":[247],"safe":[251],"tolerable":[253],"agent":[254],"prolongs":[256],"survival.":[257],"levels":[268],"are":[269],"independent":[270],"using":[275],"T-DM1.":[276]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-10-02T00:00:00"}